Stock Picks
Tagged: Equities, Stock, Stock Markets, Stock Picking, Stock Picks, Stock Trading, Stocks, Trades, Trading
- This topic has 27 replies, 2 voices, and was last updated 7 years, 7 months ago by Michael DeVries.
-
AuthorPosts
-
March 26, 2016 at 8:38 am #1529TheVCFKeymaster
This is a Topic for you to Share and Discuss your favorite Stock Picks.
Disclaimer : This is not an investment advisory, and should not be used to make investment decisions. Information in TheVCF.com Blog is often opinionated and should be considered for information purposes only. No stock exchange anywhere has approved or disapproved of the information contained herein. There is no express or implied solicitation to buy or sell securities. Any charts provided here are not meant for investment purposes and only serve as technical examples. Don’t consider buying or selling any stock without conducting your own due diligence.
- This topic was modified 6 years, 6 months ago by Michael DeVries. Reason: Added Disclaimer
March 27, 2016 at 12:35 pm #1530TheVCFKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 03/28/2018 – 04/01/2018:
1) SGYP – Synergy Pharmaceuticals, Inc.
a. Buy at < ~ $2.50
b. Sell at >~ $9.76
c. Catalysts:
1. results from the second phase 3 IBS-C trial in 2H 2016; 20160601; 20161231; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html
2. Repsonse to NDA submitted Jan 29, 2016; 20160329; 20160430; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html2) RPRX – Repros Therapeutics Inc. – Trading Below Cash
a. Buy at < ~ $0.80
b. Sell at >~ $2.70
c. Catalysts:3) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:4) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.655) CRIS – Curis, Inc.
a. Buy at < ~ $1.25
b. Sell at >~ $3.10
c. Catalysts:
1. Phase 1 update from CUDC-907, CA-170 and potential additional programs; 2016; ; https://finance.yahoo.com/news/curis-present-bio-ceo-investor-210500148.html6) BDSI – BioDelivery Sciences International, Inc.
a. Buy at < ~ $2.54
b. Sell at >~ $6.20
c. Catalysts:7) MSTX – Mast Therapeutics, Inc.
a. Buy at < ~ $0.22
b. Sell at >~ $0.50
c. Catalysts:
1. announcing top-line EPIC data to Q2, 2016; 20160401; 20160630; http://seekingalpha.com/article/3776016-why-mast-therapeutics-is-my-favorite-long-for-2016
2. MAST THERAPEUTICS TO PRESENT AT THE 10TH ANNUAL SICKLE CELL SYMPOSIUM\n\nMAST THERAPEUTICS COMPLETES PATIENT… on Sunday, April 17 • 6:30pm – 7:30pm; 20160417; 20160417; http://10thsicklecelldiseaseresear2016.sched.org/event/a101f92d0c5a30e5b8908c2a147713c8#.Vtn3TURIKKo.facebook8) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $0.14
b. Sell at >~ $0.31
c. Catalysts:
1. P1 data in April. Maybe strategic alternative; 20160401; ;9) NVET – Nexvet Biopharma Public Limited Company – Trading Below Cash
a. Buy at < ~ $2.85
b. Sell at >~ $5.80
c. Catalysts:10) CERU – Cerulean Pharma Inc. – Trading Below Cash
a. Buy at < ~ $1.90
b. Sell at >~ $3.80
c. Catalysts:11) GALE – Galena Biopharma, Inc.
a. Buy at < ~ $0.59
b. Sell at >~ $0.84What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 03/28/2018 - 04/01/2018, and Why?
April 10, 2016 at 6:18 pm #1536Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/11/2018 – 04/15/2018:
1) RBCN – Rubicon Technology, Inc. – Trading Below Cash
a. Buy at < ~ $0.65
b. Sell at >~ $4.76
c. Catalysts:2) SGYP – Synergy Pharmaceuticals, Inc.
a. Buy at < ~ $2.50
b. Sell at >~ $9.76
c. Catalysts:
1. results from the second phase 3 IBS-C trial in 2H 2016; 20160601; 20161231; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html
2. The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (IBS-C) Estimated Study Completion Date; 20160701; 20160731; https://clinicaltrials.gov/ct2/show/NCT02387359?term=IBS-C&rank=13) RPRX – Repros Therapeutics Inc. – Trading Below Cash
a. Buy at < ~ $0.80
b. Sell at >~ $2.70
c. Catalysts:4) XOMA – XOMA Corporation
a. Buy at < ~ $0.69
b. Sell at >~ $2.00
c. Catalysts:
1. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;5) FSNN – Fusion Telecommunications International, Inc.
a. Buy at < ~ $1.70
b. Sell at >~ $4.80
c. Catalysts:6) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:7) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.658) CRIS – Curis, Inc.
a. Buy at < ~ $1.25
b. Sell at >~ $3.10
c. Catalysts:
1. Phase 1 update from CUDC-907, CA-170 and potential additional programs; 2016; ; https://finance.yahoo.com/news/curis-present-bio-ceo-investor-210500148.html9) PERI – Perion Network Ltd.
a. Buy at < ~ $1.68
b. Sell at >~ $3.90
c. Catalysts:10) MSTX – Mast Therapeutics, Inc.
a. Buy at < ~ $0.22
b. Sell at >~ $0.50
c. Catalysts:
1. MAST THERAPEUTICS TO PRESENT AT THE 10TH ANNUAL SICKLE CELL SYMPOSIUM\n\nMAST THERAPEUTICS COMPLETES PATIENT… on Sunday, April 17 • 6:30pm – 7:30pm; 20160417; 20160417; http://10thsicklecelldiseaseresear2016.sched.org/event/a101f92d0c5a30e5b8908c2a147713c8#.Vtn3TURIKKo.facebook11) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $0.14
b. Sell at >~ $0.3112) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:13) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.88
b. Sell at >~ $10.74
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/11/2018 - 04/15/2018, and Why?
April 17, 2016 at 11:47 am #1542Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/18/2018 – 04/22/2018:
1) SGYP – Synergy Pharmaceuticals, Inc.
a. Buy at < ~ $2.50
b. Sell at >~ $9.76
c. Catalysts:
1. results from the second phase 3 IBS-C trial in 2H 2016; 20160601; 20161231; http://finance.yahoo.com/news/synergy-pharmaceuticals-files-drug-application-165700407.html
2. The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (IBS-C) Estimated Study Completion Date; 20160701; 20160731; https://clinicaltrials.gov/ct2/show/NCT02387359?term=IBS-C&rank=12) XOMA – XOMA Corporation
a. Buy at < ~ $0.69
b. Sell at >~ $2.00
c. Catalysts:
1. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;3) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:4) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.655) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:6) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:7) FSNN – Fusion Telecommunications International, Inc.
a. Buy at < ~ $1.68
b. Sell at >~ $3.80
c. Catalysts:8) NVET – Nexvet Biopharma Public Limited Company – Trading Below Cash
a. Buy at < ~ $2.85
b. Sell at >~ $5.80
c. Catalysts:9) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.88
b. Sell at >~ $10.74
c. Catalysts:10) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/18/2018 - 04/22/2018, and Why?
April 24, 2016 at 12:19 pm #1544Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 04/25/2018 – 04/29/2018:
1) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:2) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.653) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:4) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:5) NVET – Nexvet Biopharma Public Limited Company – Trading Below Cash
a. Buy at < ~ $2.85
b. Sell at >~ $5.80
c. Catalysts:6) CALL – magicJack VocalTec Ltd.
a. Buy at < ~ $5.83
b. Sell at >~ $10.74
c. Catalysts:7) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 04/25/2018 - 04/29/2018, and Why?
May 15, 2016 at 10:14 am #1546Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/16/2018 – 05/20/2018:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.63
b. Sell at >~ $3.92
c. Catalysts:2) BDSI – BioDelivery Sciences International, Inc.
a. Buy at < ~ $1.95
b. Sell at >~ $6.20
c. Catalysts:3) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:4) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.656) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:7) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:8) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/16/2018 - 05/20/2018, and Why?
May 22, 2016 at 7:19 pm #1547Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/23/2018 – 05/27/2018:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.63
b. Sell at >~ $3.92
c. Catalysts:2) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:3) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;4) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.656) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:7) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:8) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/23/2018 - 05/27/2018, and Why?
May 29, 2016 at 11:41 am #1548Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 05/30/2016 – 06/03/2016:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.60
b. Sell at >~ $1.85
c. Catalysts:2) IFON – Infosonics Corp.
a. Buy at < ~ $0.42
b. Sell at >~ $1.33
c. Catalysts:3) XOMA – XOMA Corporation
a. Buy at < ~ $0.65
b. Sell at >~ $2.00
c. Catalysts:
1. XOMA 358 Phase 2 test results June- July; 20160601; 20160731;
2. Phase2/proof-of-concept data from XOMA 358 and potentially Phase 3 from gevokizuamb; 2016; ;4) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.10
c. Catalysts:
1. Signal Genetics to Present at the LD Micro Invitational June 8th, at 4:00pm EST; 20160608; 20160608; http://finance.yahoo.com/news/signal-genetics-present-ld-micro-123000882.html5) DCTH – Delcath Systems, Inc. – Trading Below Cash
a. Buy at < ~ $0.25
b. Sell at >~ $0.656) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $3.59
c. Catalysts:7) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:8) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.02
b. Sell at >~ $1.80
c. Catalysts:What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 05/30/2016 - 06/03/2016, and Why?
June 12, 2016 at 12:13 pm #1551Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/13/2016 – 06/17/2016:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.85
c. Catalysts:2) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.103) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.00
c. Catalysts:4) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.74
b. Sell at >~ $1.45
c. Catalysts:5) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.50
c. Catalysts:6) ANY – Sphere 3D Corp.
a. Buy at < ~ $1.00
b. Sell at >~ $1.80
c. Catalysts:7) PLX – Protalix BioTherapeutics, Inc.
a. Buy at < ~ $0.75
b. Sell at >~ $1.05
c. Catalysts:
1. Phase 2 data of PLX-PAD (stem cells) for Intermittent claudication, or IC are due 2017; 20170101; 20171231; http://www.pluristem.com/wp-content/uploads/2016/05/IC-trial_final.pdf8) ABIO – ARCA biopharma, Inc. – Trading Below Cash
a. Buy at < ~ $3.05
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/13/2016 - 06/17/2016, and Why?
June 19, 2016 at 12:03 pm #1552Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/20/2016 – 06/24/2016:
1) SGNL – Signal Genetics, Inc.
a. Buy at < ~ $0.41
b. Sell at >~ $1.102) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.853) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.73
b. Sell at >~ $1.454) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.92
b. Sell at >~ $1.805) SCYX – SCYNEXIS, Inc.
a. Buy at < ~ $2.45
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm6) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $2.00
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=9587097) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.008) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.509) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $5.00
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=216945310) OESX – Orion Energy Systems, Inc
a. Buy at < ~ $1.17
b. Sell at >~ $1.5511) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.4012) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.38
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/20/2016 - 06/24/2016, and Why?
June 26, 2016 at 10:07 am #1553Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 06/27/2016 – 07/01/2016:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.852) SGNL – Signal Genetics, Inc. – Trading Below Cash
a. Buy at < ~ $0.41
b. Sell at >~ $1.103) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.804) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.12
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm5) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.006) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.70
b. Sell at >~ $1.457) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $1.92
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=9587098) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.509) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $4.90
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=216945310) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.12
b. Sell at >~ $1.5511) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.33
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;12) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.40What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 06/27/2016 - 07/01/2016, and Why?
July 3, 2016 at 11:44 am #1556Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at the Price Targets listed for the Week of 07/05/2016 – 07/08/2016:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.852) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.803) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.08
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm4) ISNS – Image Sensing Systems, Inc.
a. Buy at < ~ $1.90
b. Sell at >~ $4.005) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.66
b. Sell at >~ $1.456) OCRX – Ocera Therapeutics, Inc.
a. Buy at < ~ $1.76
b. Sell at >~ $3.75
c. Catalysts:
1. Phase 2b trial of OCR-002 for Hepatic encephalopathy to complete enrolment 4Q 2016. Data due shortly after.; 20160901; 20170331; http://ir.ocerainc.com/releasedetail.cfm?ReleaseID=9587097) DGLY – Digital Ally Inc.
a. Buy at < ~ $3.51
b. Sell at >~ $6.508) TCON – TRACON Pharmaceuticals, Inc.
a. Buy at < ~ $4.26
b. Sell at >~ $7.75
c. Catalysts:
1. Phase 2 data of TRC105 for Renal Cell Carcinoma due late 2016; 20160901; 20161231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
2. Phase 2 data of TRC105 and Avastin for Glioblastoma due by the end of 2016; 20160901; 20161231; ttp://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=2167620
3. Phase 2 data of TRC105 and Nexavar for Hepatocellular carcinoma due 2017; 20170101; 20171231; http://ir.traconpharma.com/phoenix.zhtml?c=253885&p=irol-newsArticle&ID=21694539) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.09
b. Sell at >~ $1.5510) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;11) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.95
b. Sell at >~ $6.40What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 07/05/2016 - 07/08/2016, and Why?
July 10, 2016 at 9:09 am #1559Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 07/11/2016 – 07/15/2016:
1) BIOC – Biocept, Inc.
a. Buy at < ~ $0.57
b. Sell at >~ $1.852) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $1.71
b. Sell at >~ $5.00
c. Catalysts:
1. P1 data in April. Maybe strategic alternative; 20160401; ;3) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.804) SCYX – SCYNEXIS, Inc. – Trading Below Cash
a. Buy at < ~ $2.08
b. Sell at >~ $4.65
c. Catalysts:
1. SCY-078 P2 oral invasive candidiasis top line June and P2 VVC top line July; 20160601; 20160731;
2. Phase 2 topline data of SCY-078 for Invasive Candida infections due July 2016; 20160701; 20160731; http://www.sec.gov/Archives/edgar/data/1178253/000162828016015866/scyx-20160331x10q.htm5) WSTL – Westell Technologies, Inc.
a. Buy at < ~ $0.66
b. Sell at >~ $1.456) OESX – Orion Energy Systems, Inc – Trading Below Cash
a. Buy at < ~ $1.09
b. Sell at >~ $1.557) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;8) DHT – DHT Holdings, Inc.
a. Buy at < ~ $4.56
b. Sell at >~ $6.40What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 07/11/2016 - 07/15/2016, and Why?
August 14, 2016 at 10:52 am #1561Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 08/15/2016 – 08/19/2016:
1) LPTN – Lpath Inc. – Trading Below Cash
a. Buy at < ~ $1.68
b. Sell at >~ $5.00
c. Catalysts:
1. P1 data in April. Maybe strategic alternative; 20160401; ;
2. hired an advisor to seek strategic alternatives including BO; 20160613; 20161231; http://stocktwits.com/message/60027010#600271392) ANY – Sphere 3D Corp.
a. Buy at < ~ $0.68
b. Sell at >~ $1.803) QLTI – QLT Inc. – Trading Below Cash
a. Buy at < ~ $1.24
b. Sell at >~ $1.75
c. Catalysts:
1. Closing of merger with AEGR; 20160701; 20160930;4) QUIK – QuickLogic Corporation
a. Buy at < ~ $0.90
b. Sell at >~ $1.73What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 08/15/2016 - 08/19/2016, and Why?
November 13, 2016 at 5:54 pm #1610Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/14/2016 – 11/18/2016:
1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.402) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.333) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/4) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/14/2016 - 11/18/2016, and Why?
November 20, 2016 at 12:33 pm #1613Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/21/2016 – 11/25/2016:
1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.402) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.333) TENX – Tenax Therapeutics Inc
a. Buy at < ~ $1.30
b. Sell at >~ $2.80
c. Catalysts:
1. topline data from Phase 3 LEVO-CTS trial in Jan’17; 20170101; 20170131; https://twitter.com/BioStocks/status/7966700204326215684) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.15
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 3 data of TNX-102 SL for Fibromyalgia due 3Q 2016; 20161001; 20161231; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=969525
2. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR6) BDSI – BioDelivery Sciences International, Inc.
a. Buy at < ~ $1.75
b. Sell at >~ $2.957) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/21/2016 - 11/25/2016, and Why?
November 27, 2016 at 5:38 pm #1614Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 11/28/2016 – 12/02/2016:
1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.402) IFON – InfoSonics Corporation – Trading Below Cash
a. Buy at < ~ $0.45
b. Sell at >~ $1.333) TENX – Tenax Therapeutics Inc
a. Buy at < ~ $1.30
b. Sell at >~ $2.80
c. Catalysts:
1. topline data from Phase 3 LEVO-CTS trial in Jan’17; 20170101; 20170131; https://twitter.com/BioStocks/status/7966700204326215684) ABIO – Arca Biopharma Inc – Trading Below Cash
a. Buy at < ~ $2.15
b. Sell at >~ $4.20
c. Catalysts:
1. Phase 2b interim analysis of Gencaro – GENETIC-AF trial for Chronic Heart Failure due 2Q 2017; 20170401; 20170630; http://www.arcabiopharma.com/arca-biopharma-announces-first-quarter-2016-financial-results-and-provides-business-update/5) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.39
b. Sell at >~ $2.456) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.15
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 3 data of TNX-102 SL for Fibromyalgia due 3Q 2016; 20161001; 20161231; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=969525
2. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR7) VJET – Voxeljet AG (ADR)
a. Buy at < ~ $3.50
b. Sell at >~ $4.75What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 11/28/2016 - 12/02/2016, and Why?
January 2, 2017 at 11:48 am #1694Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/03/2017 – 01/06/2017:
1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA2) RLJE – RLJ Entertainment Inc
a. Buy at < ~ $1.28
b. Sell at >~ $2.803) PDLI – PDL BioPharma Inc
a. Buy at < ~ $1.93
b. Sell at >~ $3.90
c. Catalysts:
1. PDL BioPharma to Present at the 2016 BIO CEO & Investor Conference; 20160209; ;
2. Q4 2016 PDL BioPharma Inc Earnings Release (Estimated)
-; 20170220; 20170220; https://www.google.com/finance?q=PDLI4) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=9975456) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS7) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTM
2. Phase 3 data due 1H 2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170630; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/03/2017 - 01/06/2017, and Why?
January 8, 2017 at 11:57 am #1695Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/09/2017 – 01/13/2017:
1) RXII – RXi Pharmaceuticals Corp
a. Buy at < ~ $0.70
b. Sell at >~ $2.90
c. Catalysts:
1. Phase 2 first cohort data due 2Q 2017. Full data due 2H 2017. – Samcyprone – RXI-SCP-1502 – Cutaneous warts – Phase 2; 20170630; 20170630; http://investors.rxipharma.com/file/Index?KeyFile=37076476
2. Phase 2 final readout due mid 2017. – RXI-109-1402 – Connective tissue growth factor ( – Phase 2; 20170731; 20170731; http://investors.rxipharma.com/file/Index?KeyFile=37076476
3. Phase 2 enrollment to be completed early 2017. Safety data readout due 2H 2017. – RXI-109-1501 – Retinal scarring – Phase 1/2; 20171231; 20171231; http://investors.rxipharma.com/file/Index?KeyFile=370764762) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA3) ATNM – Actinium Pharmaceuticals Inc
a. Buy at < ~ $0.86
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 2 initiated September 2016. Interim analysis due mid-2017. – Actimab-A – Acute Myeloid Leukemia ( – Phase 2; 20170731; 20170731; http://ir.actiniumpharma.com/press-releases/detail/203
2. Phase 3 initiated June 2016. Data due 1H 2018. – Iomab-B – Hematopoietic Stem Cells Transplantation – Phase 3; 20180630; 20180630; http://ir.actiniumpharma.com/press-releases/detail/2034) RLJE – RLJ Entertainment Inc
a. Buy at < ~ $1.28
b. Sell at >~ $2.805) PDLI – PDL BioPharma Inc
a. Buy at < ~ $1.93
b. Sell at >~ $3.90
c. Catalysts:
1. PDL BioPharma to Present at the 2016 BIO CEO & Investor Conference; 20160209; ;
2. Q4 2016 PDL BioPharma Inc Earnings Release (Estimated)
-; 20170220; 20170220; https://www.google.com/finance?q=PDLI6) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA7) ARQL – ArQule, Inc.
a. Buy at < ~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Q4 2016 ArQule Inc Earnings Release (Estimated)
-; 20170227; 20170227; https://www.google.com/finance?q=ARQL
2. Phase 3 – Tivantinib (ARQ 197) METIV-HCC trial – Previously treated Inoperable Hepatocellular Carcinoma cancer – Phase 3; 20170331; 20170331; http://investors.arqule.com/releasedetail.cfm?ReleaseID=9979148) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=9975459) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS10) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Phase 3 data due 1H 2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170101; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385
2. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTMWhat do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/09/2017 - 01/13/2017, and Why?
January 22, 2017 at 12:57 pm #1721Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 01/23/2017 – 01/27/2017:
1) ROKA – Roka Bioscience Inc – Trading Below Cash
a. Buy at < ~ $3.66
b. Sell at >~ $14.40
c. Catalysts:
1. Q4 2016 Roka Bioscience Inc Earnings Release (Estimated)
-; 20170302; 20170302; https://www.google.com/finance?q=ROKA2) FLKS – Flex Pharma Inc
a. Buy at < ~ $4.41
b. Sell at >~ $12.00
c. Catalysts:
1. Q4 2016 Flex Pharma Inc Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=FLKS
2. Phase 2 initiated June 2016. Readout due 2H2017. – FLX-787 – Multiple Sclerosis – Phase 2; 20171231; 20171231; http://ir.flex-pharma.com/phoenix.zhtml?c=253862&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMjgwNTY0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU3
3. Phase 2 initiated September 2016. Readout due 2017/18. – FLX-787 – Amyotrophic lateral sclerosis ( – Phase 2; 20180630; 20180630; http://ir.flex-pharma.com/phoenix.zhtml?c=253862&p=irol-SECText&TEXT=aHR0cDovL2FwaS50ZW5rd2l6YXJkLmNvbS9maWxpbmcueG1sP2lwYWdlPTExMjgwNTY0JkRTRVE9MCZTRVE9MCZTUURFU0M9U0VDVElPTl9FTlRJUkUmc3Vic2lkPTU33) ATNM – Actinium Pharmaceuticals Inc
a. Buy at < ~ $0.86
b. Sell at >~ $2.15
c. Catalysts:
1. Phase 2 initiated September 2016. Interim analysis due mid-2017. – Actimab-A – Acute Myeloid Leukemia ( – Phase 2; 20170731; 20170731; http://ir.actiniumpharma.com/press-releases/detail/203
2. Phase 3 initiated June 2016. Data due 1H2018. – Iomab-B – Hematopoietic Stem Cells Transplantation – Phase 3; 20180630; 20180630; http://ir.actiniumpharma.com/press-releases/detail/2034) TISA – Top Image Systems Ltd.
a. Buy at < ~ $1.17
b. Sell at >~ $2.45
c. Catalysts:
1. Q4 2016 Top Image Systems Ltd Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=TISA5) ARQL – ArQule, Inc.
a. Buy at < ~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Q4 2016 ArQule Inc Earnings Release (Estimated)
-; 20170227; 20170227; https://www.google.com/finance?q=ARQL
2. Phase 3 – Tivantinib (ARQ 197) METIV-HCC trial – Previously treated Inoperable Hepatocellular Carcinoma cancer – Phase 3; 20170331; 20170331; http://investors.arqule.com/releasedetail.cfm?ReleaseID=9979146) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Q2 2017 Aviragen Therapeutics Inc Earnings Release (Estimated)
-; 20170203; 20170203; https://www.google.com/finance?q=AVIR
2. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170214; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=9975457) NVLS – Nivalis Therapeutics Inc – Trading Below Cash
a. Buy at < ~ $2.00
b. Sell at >~ $3.00
c. Catalysts:
1. N91115 Cystic Fibrosis – one copy of the F508del mutation and a second mutation that results in a gating defect in the CFTR protein Phase 2
Phase 2 data due 1Q 2017.; 20170101; 20170330; http://biopharmcatalyst.com/companies/company-pipeline-database#sort=company
2. Q4 2016 Nivalis Therapeutics Inc Earnings Release (Estimated); 20170227; 20170227; https://www.google.com/finance?q=NVLS8) VSTM – Verastem Inc – Trading Below Cash
a. Buy at < ~ $1.07
b. Sell at >~ $1.50
c. Catalysts:
1. Phase 3 data due 1H2017. – Duvelisib – DUO – Cancer – relapsed/refractory chronic lymphocytic leukemia ( – Phase 3; 20170101; 20170630; http://phoenix.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-newsArticle&ID=2218385
2. Q4 2016 Verastem Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=VSTMWhat do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 01/23/2017 - 01/27/2017, and Why?
February 5, 2017 at 10:07 am #1750Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/06/2017 – 02/10/2017:
1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at <~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT2) AGLE – Aeglea Bio Therapeutics Inc
a. Buy at <~ $3.89
b. Sell at >~ $8.20
c. Catalysts:
1. Phase 1 to initiated 1H 2016. Top-line data due 1H2017 – AEB1102 – Arginase I deficiency – Phase 1; 20170101; 20170630; http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=254096&fid=14657424
2. Aeglea BioTherapeutics To Present New Data At 2017 ACMG Annual Clinical Genetics Meeting; 20170321; 20170325; https://www.thestreet.com/story/13956618/1/aeglea-biotherapeutics-to-present-new-data-at-2017-acmg-annual-clinical-genetics-meeting.html3) MICT – Micronet Enertec Technologies Inc
a. Buy at <~ $1.14
b. Sell at >~ $2.404) ONCS – OncoSec Medical Inc
a. Buy at <~ $1.20
b. Sell at >~ $2.10
c. Catalysts:
1. Immune monitoring data at ASCO-SITC, Feb 23; 20170223; 20170223; http://immunosym.org/
2. Q2 2017 OncoSec Medical Inc Earnings Release (Estimated)
-; 20170306; 20170306; https://www.google.com/finance?q=ONCS5) AVIR – Aviragen Therapeutics Inc – Trading Below Cash
a. Buy at <~ $1.14
b. Sell at >~ $2.00
c. Catalysts:
1. Phase 2b top-line data due early February 2017. – Vapendavir – SPIRITUS trial – Human rhinovirus ( – Phase 2b; 20170201; 20170214; http://investors.aviragentherapeutics.com/releasedetail.cfm?ReleaseID=997545What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/06/2017 – 02/10/2017, and Why?
February 12, 2017 at 11:41 am #1789Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/13/2017 – 02/17/2017:
1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT2) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.70
c. Catalysts:
1. Q2 2017 Nexvet Biopharma plc Earnings Release (Estimated); 20170214; 20170214; https://www.google.com/finance?q=NVET3) AGLE – Aeglea Bio Therapeutics Inc
a. Buy at < ~ $3.89
b. Sell at >~ $8.20
c. Catalysts:
1. Phase 1 to initiated 1H 2016. Top-line data due 1H2017 – AEB1102 – Arginase I deficiency – Phase 1; 20170101; 20170630; http://services.corporate-ir.net/SEC.Enhanced/SecCapsule.aspx?c=254096&fid=14657424
2. Aeglea BioTherapeutics To Present New Data At 2017 ACMG Annual Clinical Genetics Meeting; 20170321; 20170325; https://www.thestreet.com/story/13956618/1/aeglea-biotherapeutics-to-present-new-data-at-2017-acmg-annual-clinical-genetics-meeting.html4) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $2.40What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/13/2017 - 02/17/2017, and Why?
February 19, 2017 at 2:04 pm #1799Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/20/2017 – 02/24/2017:
1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT2) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.703) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $2.404) HSON – Hudson Global Inc – Trading Below Cash
a. Buy at < ~ $1.20
b. Sell at >~ $1.54
c. Catalysts:
1. Q4 2016 Hudson Global Inc Earnings Release (Estimated); 20170301; 20170301; https://www.google.com/finance?q=HSONWhat do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/20/2017 - 02/24/2017, and Why?
February 27, 2017 at 6:52 am #1849Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 02/27/2017 – 03/03/2017:
1) XTNT – Xtant Medical Holdings Inc – Trading Below Cash
a. Buy at < ~ $0.31
b. Sell at >~ $0.84
c. Catalysts:
1. The company expects to launch four to six new products in 2017 to help drive revenue growth in 2018 and beyond; 20170131; 20171231; http://seekingalpha.com/instablog/44479986-leny-hettmansperger/4952733-xtnt-34c-ceo-resigns-leaving-behind-stronger-company-significant-upside-potential
2. Q4 2016 Xtant Medical Holdings Inc Earnings Release (Estimated)
-; 20170313; 20170313; https://www.google.com/finance?q=XTNT2) TRVN – Trevena Inc
a. Buy at < ~ $3.70
b. Sell at >~ $8.00
c. Catalysts:
1. Q4 2016 Trevena Inc Earnings Release (Estimated)
-; 20170307; 20170307; https://www.google.com/finance?q=TRVN3) NVET – Nexvet Biopharma plc
a. Buy at < ~ $2.66
b. Sell at >~ $5.704) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $1.58What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 02/27/2017 - 03/03/2017, and Why?
March 5, 2017 at 12:28 pm #1921Michael DeVriesKeymasterThe following are the Stock Symbols on my Watchlist to Buy if/when they bottom out at the Buy at Price Targets listed below for the Week of 03/06/2017 – 03/10/2017:
1) TKAI – Tokai Pharmaceuticals Inc – Trading Below Cash
a. Buy at < ~ $0.73
b. Sell at >~ $1.80
c. Catalysts:
1. Merger with Otic Pharma Ltd; 20170101; 20170630; http://seekingalpha.com/filing/3366062#D307733DPREM14A_HTM_TOC307733_5
2. Merger may be terminated if the Otic Transaction is not consummated by April 30, 2017; 20170301; 20170430; http://seekingalpha.com/filing/3366062#D307733DPREM14A_HTM_TOC307733_52) TRVN – Trevena Inc
a. Buy at < ~ $3.70
b. Sell at >~ $8.00
c. Catalysts:
1. Q4 2016 Trevena Inc Earnings Release (Estimated)
-; 20170307; 20170307; https://www.google.com/finance?q=TRVN3) CYCC – Cyclacel Pharmaceuticals Inc
a. Buy at < ~ $3.42
b. Sell at >~ $5.60
c. Catalysts:
1. A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors; 20180701; 20180731; https://www.clinicaltrials.gov/ct2/show/NCT00999401?term=Cyclacel&recr=Open&rank=2
2. Q4 2016 Cyclacel Pharmaceuticals Inc Earnings Release (Estimated)
-; 20170322; 20170322; https://www.google.com/finance?q=CYCC
3. Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23) Phase 2; 20190701; 20190731; https://www.clinicaltrials.gov/ct2/show/NCT01253460?term=Cyclacel&rank=11
4. Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation (ROSCO-CF); 20180801; 20181031; https://www.clinicaltrials.gov/ct2/show/NCT02649751?term=Cyclacel&recr=Open&rank=34) OASM – Oasmia Pharmaceutical AB
a. Buy at < ~ $1.70
b. Sell at >~ $2.50
c. Catalysts:
1. 1. Doxophos appr. Russia. 2. Apealea appr. Europe (ovarian cancer & metastatic breast cancer) 3. Comm. agreement Apealea 4. Positive cash flow 5. Several license agreements of nano technology XR17 (similar to Celator) and lots more to come; 20170101; 20171231; https://stocktwits.com/swedetrader/message/76192391
2. “@PeyoteBetting Hopefully a permission from EMA for sale of Paclical in Europe. Meeting scheduled in March”; 20170301; 20170331;5) MICT – Micronet Enertec Technologies Inc
a. Buy at < ~ $1.14
b. Sell at >~ $1.58What do you think about these Stock Picks to Buy at these Price Targets?
What other Stock Symbols do you all think are the Best Stocks <~ $10 to Buy next week, 03/06/2017 - 03/10/2017, and Why?
-
AuthorPosts
- You must be logged in to reply to this topic.